Dexelvucitabine (INCB-8721; PSI-5582; YZ-817; DPC-817; DOC-817) is a novel and potent nucleoside reverse transcriptase inhibitor that has failed clinical trials for the management of HIV infection.

纯度：≥98%

CAS：134379-77-4